Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Anticancer Research|May 6, 2021
Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal CancerMasakatsu Numata, Hiroshi Tamagawa, Keisuke Kazama, et al.
Anticancer Research|July 5, 2020
The Impact of Severe Infectious Complications on Long-term Prognosis for Gastric CancerYukio Maezawa, Toru Aoyama, Mihwa Ju, et al.
Anticancer Research|February 4, 2019
Influence of Postoperative Surgical Complications After Gastrectomy on Body Weight and Body Composition Changes in Patients With Gastric CancerToru Aoyama, Takaki Yoshikawa, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|October 26, 2021
The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric CancerToru Aoyama, Masato Nakazono, Kenki Segami, et al.
In Vivo (Athens, Greece)|April 27, 2023
Prognostic Nutritional Index as a Predictor of Prognosis in Postoperative Patients With Gastric CancerTetsushi Ishiguro, Toru Aoyama, Mihwa Ju, et al.
Anticancer Research|October 1, 2021
Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?Yosuke Atsumi, Masakatsu Numata, Keisuke Kazama, et al.
In Vivo (Athens, Greece)|July 8, 2019
Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted TherapyAkio Higuchi, Toru Aoyama, Keisuke Kazama, et al.
Journal of Gastrointestinal Cancer|October 2, 2023
The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Anticancer Research|April 4, 2021
Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal CancerTakuo Watanabe, Manabu Shiozawa, Yayoi Kimura, et al.
In Vivo (Athens, Greece)|January 6, 2021
Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab MonotherapyHayato Watanabe, Takanobu Yamada, Keisuke Komori, et al.
Pageof 18